Float follows ‘North Star’ to growth 

SAN FRANCISCO – With its latest round of funding, Float, a provider of on-demand home infusion staffing and technology, is poised to expand its “frictionless” solutions, says CEO Ryan Johnson. 

The $10 million in Series A funding, announced in April, has allowed the company to quickly scale its solutions and expand into Arizona. 

“Each month, we’re staffing over 1,800 visits and this month we were up 15% month on month, so we continue to grow quite quickly,” said Johnson, a former ER nurse. “Every one of those patients we serve is one less patient having to go to the hospital or infusion center. That’s our North Star metric.” 

Johnson launched Float in 2021 in response to labor constraints in the home infusion market. It currently counts industry giants like Optum, CVS, Option Care, Alliance RX (Walgreen's), Kroger, Kabafusion and Soleo Health among its clients. 

But when it comes to labor, it’s not just quantity, it’s quality, says Johnson – that’s the real difference maker. 

“What’s really requisite is having nurses of exceptional quality, in terms of their technical skills to give these types of drugs and monitor a patient throughout,” he said. “They can serve as liaisons between the patient and the health system at large to ensure better outcomes.” 

Where Float also comes into play: its technology, which not only allows clients to route nursing requests to the company, but also removes much of the administrative burdens of managing the workforce and supports back-end functions such as providing nursing notes in a consistent, says Johnson. 

“I believe that this is not only where health care is going, but where it needs to go,” he said. “Every time we staff a visit, then we’re providing preventative care that is keeping patients happy and healthy at home, with greater capital efficiency. Everybody wins the more this type of care moves to the home.”